You are here

A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Gainesville, Florida, 32608 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy, Elderly
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
65-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male and/or female subjects.

- Subjects must be in reasonably good health as determined by the investigator based on
medical history, full physical examination (including blood pressure and pulse rate
measurement), 12 lead ECG and clinical laboratory tests.

- Subjects with mild, chronic, stable disease (eg, controlled hypertension, non-insulin
dependent diabetes, osteoarthritis may be enrolled if deemed medically prudent by the
investigator.

- Subjects taking daily prescription or non-prescription medications for management of
acceptable chronic medical conditions must be on a stable dose.

- Body Mass Index (BMI) between 18 to 30 kg/m2, inclusive; and a total body weight >50
kg (110 lbs).

- Creatinine clearance greater than 30 mL/min using the Cockcroft-Gault method.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with evidence or history of clinically significant hematological, renal,
endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric,
neurologic, immunologic, or allergic disease.

- Use of tobacco or any form of nicotine in the past 6 months.

- Greater than 7 drinks of alcohol per week for women, and greater than 14 drinks of
alcohol per week for men.

NCT00832052
Pfizer
Completed
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease, Healthy
NCT00441987
Males
20+
Years
5-4-12, Kitashinagawa, Shinagawa-ku
Healthy Subjects
NCT00379860
All Genders
Healthy
NCT01437839
All Genders
21+
Years
Singapore,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

Clinical[email protected]

Call Now